Company: LCTX
Filing Date: 2025-03-10
Form Type: 10-K
Source: 0000950170-25-036309
Chunk: 5

Company: Lineage Cell Therapeutics, Inc.
Filing Date: 2025-03-10
Form: 10-K
Item: Item 15
Chunk 5
---
 Cell Cure Neurosciences Ltd., and Registrant
     
    10.13
     
    10-K
     
    March 10, 2022
     
    001-12830

    19.01*
     
    Insider Trading Policy effective June 11, 2024

    OTHER EXHIBITS

    21.01*
     
    List of Subsidiaries of the Registrant

    23.01*
     
    Consent of Moss Adams LLP

    23.02*
     
    Consent of WithumSmith+Brown, PC

    31.01*
     
    Certification of Chief Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002

    31.02*
     
    Certification of Chief Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002

    32.01#
     
    Certifications of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

    97
     
    Lineage Cell Therapeutics, Inc. Clawback Policy
     
     97
     
     10-K
     
     March 7, 2024
     
     001-12830

    101.INS*
     
    XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

    101.SCH*
     
    Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents

    104*
     
    Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

^ The schedules and exhibits to the merger agreement have been omitted pursuant to Item 601(b)(2) of Regulation S-K. A copy of any omitted schedule and/or exhibit will be furnished to the Securities and Exchange Commission upon request.

* Filed herewith.

# Furnished herewith.

+ Indicates management contract or compensatory plan or arrangement.

† Portions of this exhibit have been omitted pursuant to a request for confidential treatment.

†† Certain information in this exhibit has been omitted pursuant to Item 601 of Regulation S-K